The First Case of Multiple Myeloma Treated With ASCT followed by Anti-BCMA CART Cells using Retroviral Vector
guo zhi,
Liu Liqiong,
zhu wenxiang
et al.
Abstract:B- cell maturation antigen (BCMA) -targeted chimeric antigen receptor-T (CART) cell therapy has shown great promise in the treatment of relapsed/refractory multiple myeloma (MM). In this case, we reported a case of a 41-year-old male patient with MM who finally developed multi-line drug resistance, refractoriness and bone marrow suppression after multiple lines of high-intensity chemotherapy. After physician evaluation, this patient was recommended to receive autologous hematopoietic stem cell transplantation … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.